Literature DB >> 14524531

c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells.

E Gregory MacEwen1, Jon Kutzke, Jennifer Carew, Josep Pastor, Julie A Schmidt, Rachel Tsan, Douglas H Thamm, Robert Radinsky.   

Abstract

To further characterize the role of hepatocyte growth factor-scatter factor (HGF-SF) and its receptor (c-Met) in osteosarcoma (OS), human OS cell lines with low (SAOS-2) and high (SAOS-LM2) metastatic potential, and cell lines derived from spontaneous canine OS were studied. All cell lines were evaluated for c-Met and HGF-SF expression and receptor activation using Northern, RT-PCR, and Western blot analyses, respectively. Functional activity of receptor-ligand interaction was measured using c-Met phosphorylation status, proliferation assays (anchorage-dependent and -independent), Matrigel invasion, modulation of urokinase plasminogen activator (uPA) expression, and cell dispersion (scattering). All cell lines exhibited steady-state mRNA expression of c-Met. The canine OS cell lines also expressed HGF-SF mRNA as determined by RT-PCR analysis. Western analysis showed c-Met protein expression and HGF-stimulated (human) or constitutive (canine) receptor autophosphorylation. Treatment with recombinant human HGF resulted in enhanced proliferation in 3 of 5 OS cell lines and enhanced colony formation in 2 of 5 OS cell lines. Matrigel invasion was significantly enhanced in 3 of the cell lines and uPA levels were significantly increased in the SAOS-2 cells following HGF treatment. Scattering was enhanced in both the SAOS-2 and SAOS-LM2 cells. These data support the involvement of c-Met and HGF-SF in the growth and progression of human and canine OS, and may offer new targets for the development of therapeutic strategies for OS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14524531     DOI: 10.1023/a:1025404603315

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  93 in total

1.  Hepatocyte growth factor protects functional and histological disorders of HgCl(2)-induced acute renal failure mice.

Authors:  Naoki Yamasaki; Tomokazu Nagano; Ikue Mori-Kudo; Atsushi Tsuchida; Takao Kawamura; Hitoshi Seki; Mutsuo Taiji; Hiroshi Noguchi
Journal:  Nephron       Date:  2002-02       Impact factor: 2.847

2.  Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3'-kinase is a critical mediator of tumor invasion.

Authors:  L Kotelevets; V Noë; E Bruyneel; E Myssiakine; E Chastre; M Mareel; C Gespach
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

Review 3.  Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness.

Authors:  F Blasi
Journal:  Bioessays       Date:  1993-02       Impact factor: 4.345

4.  Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts.

Authors:  K Matsumoto; H Okazaki; T Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1992-10-15       Impact factor: 3.575

5.  Met expression and sarcoma tumorigenicity.

Authors:  S Rong; M Jeffers; J H Resau; I Tsarfaty; M Oskarsson; G F Vande Woude
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

Review 6.  Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase.

Authors:  C Birchmeier; E Gherardi
Journal:  Trends Cell Biol       Date:  1998-10       Impact factor: 20.808

Review 7.  Scatter factor and angiogenesis.

Authors:  E M Rosen; I D Goldberg
Journal:  Adv Cancer Res       Date:  1995       Impact factor: 6.242

8.  Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients.

Authors:  S Rong; L A Donehower; M F Hansen; L Strong; M Tainsky; M Jeffers; J H Resau; E Hudson; I Tsarfaty; G F Vande Woude
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

9.  Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas.

Authors:  C Liu; M Park; M S Tsao
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

10.  An epithelial scatter factor released by embryo fibroblasts.

Authors:  M Stoker; M Perryman
Journal:  J Cell Sci       Date:  1985-08       Impact factor: 5.285

View more
  20 in total

Review 1.  Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro.

Authors:  Patrick J Messerschmitt; Ashley N Rettew; Robert E Brookover; Ryan M Garcia; Patrick J Getty; Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2008-07-08       Impact factor: 4.176

2.  MicroRNA-613 suppresses proliferation, migration and invasion of osteosarcoma by targeting c-MET.

Authors:  Xinyu Li; Xufang Sun; Jing Wu; Zhihong Li
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

3.  miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met.

Authors:  Guangfeng Niu; Bin Li; Jianmin Sun; Li Sun
Journal:  Cell Prolif       Date:  2015-04-16       Impact factor: 6.831

4.  Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin.

Authors:  X Wan; S Y Kim; L M Guenther; A Mendoza; J Briggs; C Yeung; D Currier; H Zhang; C Mackall; W-J Li; R S Tuan; A T Deyrup; C Khanna; L Helman
Journal:  Oncogene       Date:  2009-07-13       Impact factor: 9.867

Review 5.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

Review 6.  Translational biology of osteosarcoma.

Authors:  Maya Kansara; Michele W Teng; Mark J Smyth; David M Thomas
Journal:  Nat Rev Cancer       Date:  2014-10-16       Impact factor: 60.716

Review 7.  Novel targets with potential therapeutic applications in osteosarcoma.

Authors:  Chand Khanna
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

8.  Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.

Authors:  Jordan Ayers; Rowan J Milner; Galaxia Cortés-Hinojosa; Alberto Riva; Sandra Bechtel; Bikash Sahay; Matthew Cascio; Amandine Lejeune; Keijiro Shiomitsu; Carlos Souza; Oscar Hernandez; Marc Salute
Journal:  J Vet Diagn Invest       Date:  2021-01-15       Impact factor: 1.279

9.  Characterization of STAT3 activation and expression in canine and human osteosarcoma.

Authors:  Stacey L Fossey; Albert T Liao; Jennifer K McCleese; Misty D Bear; Jiayuh Lin; Pui-Kai Li; William C Kisseberth; Cheryl A London
Journal:  BMC Cancer       Date:  2009-03-10       Impact factor: 4.430

10.  Breed-predispositions to cancer in pedigree dogs.

Authors:  Jane M Dobson
Journal:  ISRN Vet Sci       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.